{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Attenuated respiratory syncytial virus vaccine compositions", "item": "https://www.patentleaderboard.com/patent/5882651"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Attenuated respiratory syncytial virus vaccine compositions

Attenuated respiratory syncytial virus vaccine compositions

US Patent 5882651 · Granted Mar 16, 1999

Estimated economic value: $709,005,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Peptide vaccine based on a new universal influenza a hemagglutinin head domain e2025
Human monoclonal antibodies to enterovirus D682025
Human immunodeficiency virus-specific T cell receptors2025
Human monoclonal antibodies to a new universal influenza A hemagglutinin head do2025
Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C viru2025
Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (2025
Neutralizing antibodies to GP120 and their use2025
Development of dengue virus vaccine components2025
Human monoclonal antibodies that neutralize pandemic GII.4 noroviruses2025
10E8 neutralizing antibody variants that bind to the MPER region of HIV-1 GP41 a2024
Human monoclonal antibodies against yellow fever virus and uses therefor2024
Human West Nile virus antibodies and methods of use therefor2024